NEJM - Rosuvastatin for ARDS

"Rosuvastatin for Sepsis-Associated Acute Respiratory Distress Syndrome"
http://www.nejm.org/doi/full/10.1056/NEJMoa1401520
"CONCLUSIONS

Rosuvastatin therapy did not improve clinical outcomes in patients with sepsis-associated ARDS and may have contributed to hepatic and renal organ dysfunction."